• Obama Seeks To Make Mark On Genetic Medicine

    Forbes |  After a few weeks of hype around the Obama administration's efforts to speed cancer research, officials tonight announced plans to kickstart efforts around the president's Precision Medicine Initiative.

    Jul 7, 2016

  • In clinical trials for-profit review boards staged a revolution

    STAT |  The rise of commercial institutional review boards has led to questions over whether they can adequately protect the safety of study participants.

    Jul 6, 2016

  • News and Products from DIA 2016

    Clinical Informatics News Roundup | News and announcements are coming fast out of the Drug Industry Association meeting in Philadelphia. Highlights here come from DrugDev, Veeva, inVentiv, Bracket, and MasterControl. The roundup will be updated throughout the week.

    Jun 28, 2016

  • It’s Site Selection, Not a Toss of the Dice

    Clinical Informatics News | Guest Commentary | Conducting clinical trials is a high stakes game, but disturbingly, the risk of selecting non-performing or underperforming investigative sites is greater than losing at the gambling table. When shooting craps, for example, odds are 17% that the player will role a 7 to start the action, and the odds of actually winning may be even lower. But, the odds of selecting sites that perform well in clinical trials are worse, far worse.

    Jun 27, 2016

  • CIOs tell ONC Its time to let the EHR market innovate to drive interoperability

    Healthcare IT News |  Several experts contend that the Office of the National Coordinator for Health IT is attacking the wrong problems and the last thing anyone needs is more prescriptive regulation about EHR functionality, usability and quality measurement.

    Jun 27, 2016

  • Reality check from Eric Lander Cancer cure isnt around the corner

    STAT |  Eric Lander says it will take several decades to find a cure for cancer. Speaking at the Aspen Ideas Festival, Lander said patient data sharing would make the difference.

    Jun 27, 2016

  • Clinical informaticist says the best is yet to come for FHIR

    Healthcare IT News |  InterSystems' Russell Leftwich, MD, says 'there's still a lot of data yet to be incorporated' with the HL7 standard.

    Jun 24, 2016

  • NEA Leads $44M Bet That Protecting Synapses Will Help Fight Alzheimers

    Forbes |  Alzheimer's might be the most frustrating graveyard in pharmaceutical R&D. Billions are being wagered on the idea that reducing amyloid plaque buildups will help slow or stop the memory loss and cognitive decline in old age. Nothing really works. Now a startup in South San Francisco has raised $44 million to take a different tack.

    Jun 23, 2016

  • Quintiles Accelerating Precision Trial Enrollment

    Clinical Informatics News | As clinical trials become more complex and zero in on narrower patient populations, time spent in site start-up is increasing. To address this growing problem and identify and enroll hard-to-find patients more quickly, Quintiles recently launched its Precision Enrollment program, which is designed to activate site start-up within 21 days of patient identification.

    Jun 22, 2016

  • EMA and FDA Begin Collaborations on Patient Engagement

    RAPS |  On Wednesday, the European Medicines Agency and the US Food and Drug Administration began exchanging more information on the best practices of involving patients in the development, evaluation, and post-authorization tracking of medicines.

    Jun 22, 2016

  • WIRB-Copernicus Group Acquires CenterWatch

    Clinical Informatics News Brief | WIRB-Copernicus Group announced its acquisition of CenterWatch today. Kenneth A. Getz, CenterWatch founder and owner, will join the WCG board of directors. The CenterWatch leadership remains the same.

    Jun 22, 2016

  • Federal Oversight Group Has Complaints But Says Yes To CRISPR Trial

    Xconomy |  Despite worries about conflict of interest, a National Institutes of Health committee that oversees the use of gene therapy and other cutting edge biomedical technologies voted today to let researchers move ahead with the CRISPR-Cas9 clinical trial.

    Jun 21, 2016